STOCK TITAN

BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) will present the next installment of its BD Innovates series, highlighting its Pharmaceutical Systems business on December 11, 2023, at 11:30 am Eastern Time. The series showcases BD's innovation, products, and pipeline in support of its BD 2025 Strategy. The live webcast can be accessed from the BD investor relations website, investors.bd.com.
Positive
  • None.
Negative
  • None.

FRANKLIN LAKES, N.J., Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will highlight its Pharmaceutical Systems business on Monday, December 11, 2023, at 11:30 am Eastern Time. The BD Innovates series spotlights BD's innovation, products and pipeline in support of its BD 2025 Strategy.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and on X (formerly known as Twitter) @BDandCo.

Contacts:




Media:

Investors:

Troy Kirkpatrick

 Adam Reiffe

VP, Public Relations

Sr. Director, Investor Relations

858.617.2361

201.847.6927

troy.kirkpatrick@bd.com      

adam.reiffe@bd.com 

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-to-present-next-installment-of-bd-innovates-series-spotlight-on-pharmaceutical-systems-302005084.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

What is the date of BD's next BD Innovates series presentation?

BD's next BD Innovates series presentation is scheduled for December 11, 2023.

What time will the BD Innovates series presentation take place?

The presentation will start at 11:30 am Eastern Time on December 11, 2023.

Where can I access the live webcast of BD's presentation?

The live webcast can be accessed from the BD investor relations website, investors.bd.com.

Will there be a replay of the event available?

Yes, a replay of the event will be available on the same webpage following its conclusion.

Becton, Dickinson and Co.

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Stock Data

69.44B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
FRANKLIN LAKES

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.